Sh. Bigner et al., Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization, AM J PATH, 155(2), 1999, pp. 375-386
Citations number
25
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Oligodendroglial neoplasms are a subgroup of gliomas with distinctive morph
ological characteristics. In the present study we have evaluated a series o
f these tumors to define their molecular profiles and to determine whether
there is a relationship between molecular genetic parameters and histologic
al pattern in this tumor type. Loss of heterozygosity (LOH) for 1p and 19q
was seen in 17/23 (74%) well-differentiated oligodendrogliomas, in. 18/23 (
83%) anaplastic oligodendrogliomas, and in 3/8 (38%) oligoastrocytomas grad
es II and III. LOH for 17p and/or mutations of the TP53 gene occurred in 14
of these 55 tumors. Only one of the 14 cases with 17p LOH/TP53 gene mutati
on also had LOH for Ip and 19q, and significant astrocytic elements mere se
en histologically in the majority of these 14 tumors. LOH for 9p and/or del
etion of the CDKN2A gene occurred in 15 of these 55 tumors, and 11 of these
cases were among the 24 (42%) anaplastic oligodendrogliomas. Comparative g
enomic hybridization (CGH) identified the majority of cases with Ip and 19q
loss and, in addition, showed frequent loss of chromosomes ri, 14, 15, and
18. These findings demonstrate that oligodendroglial neoplasms usually hav
e loss of Ip and 19q whereas astrocytomas of the progressive type frequentl
y contain mutations of the TP53 gene, and that 9p loss and CDKN2A deletions
are associated with progression from well-differentiated to anaplastic oli
godendrogliomas.